TrialEuropean journal of clinical pharmacology2016

Can an early phase clinical pharmacology study replace a thorough QT study? Experience with a novel H3-receptor antagonist/inverse agonist.

Rashmi R Shah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.